Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
AbbVie Declares Quarterly Dividend
09:07am, Friday, 05'th Sep 2025
NORTH CHICAGO, Ill. , Sept. 5, 2025 The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.64 per share.
Will AbbVie's Neuroscience Portfolio Continue to Aid Top-line Growth?
10:21am, Thursday, 04'th Sep 2025
ABBV's expanding neuroscience portfolio, led by Botox, Vraylar and new launches like Vyalev, continues to fuel top-line growth.
Could These 3 Dividend Kings Be Worth $1 Trillion in 10 Years?
04:09am, Thursday, 04'th Sep 2025
The list of trillion-dollar stocks is small and doesn't feature a single medical company. That might change in the next decade, as several leading healthcare stocks have market caps that are inching c
Global drugmakers rush to boost US presence as tariff threat looms
02:09pm, Wednesday, 03'rd Sep 2025
Global drugmakers are scrambling to shore up their U.S. manufacturing capacity and domestic inventory as the Trump administration weighs hefty tariffs on pharmaceutical imports into the country.
Data presented at 13th Society of Hematologic Oncology (SOHO) Annual Meeting NORTH CHICAGO, Ill. , Sept. 3, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced updated results from the Phase 2 EP
AbbVie to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
08:00am, Tuesday, 02'nd Sep 2025
NORTH CHICAGO, Ill. , Sept. 2, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9, 2025.
Investing in the Age of Longevity: Silver Economy Stocks in Focus
01:16pm, Monday, 01'st Sep 2025
AbbVie, Amgen, Stryker and Dexcom are tapping into the booming silver economy with new therapies, tech and acquisitions aimed at aging populations.
Wall Street Week Ahead
06:09am, Sunday, 31'st Aug 2025
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
5 High-Yield Dividend Stocks I Plan on Holding for the Next 10 Years or Longer
04:44am, Sunday, 31'st Aug 2025
Exercising patience might be the most difficult part of investing. However, I find it much easier to patiently own some stocks more than others.
How To Invest $100,000 In A Near-Perfect Strategy Portfolio
08:05am, Saturday, 30'th Aug 2025
Market timing is futile; a disciplined, diversified, and rules-based approach is essential for long-term investing success. A Near-Perfect Strategy portfolio aims for consistent income, growth, and lo
The Smartest Dividend Stocks to Buy With $500 Right Now
04:51am, Saturday, 30'th Aug 2025
You don't have to be rich to make money. Furthermore, you don't have to have a lot of money to begin making money almost immediately.
AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin
12:37pm, Friday, 29'th Aug 2025
President Trump's threats against Big Pharma do not prevent AbbVie shares from rising. AbbVie's strong financial results for the second quarter of 2025 were ensured by its two superstars, Rinvoq and S
ABBV or MRK: Which Stock Should Investors Place Their Bet on in 2025?
11:21am, Friday, 29'th Aug 2025
AbbVie edges past Merck in 2025 as strong Skyrizi and Rinvoq sales, pipeline gains and rising estimates fuel growth momentum.
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
10:00am, Friday, 29'th Aug 2025
AbbVie (ABBV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Best Dividend Aristocrats For September 2025
02:09pm, Wednesday, 27'th Aug 2025
Dividend Aristocrats have shown mixed 2025 performance, with some delivering double-digit gains and others lagging, but overall stability remains a hallmark. Dividend growth is robust, with 53 of 69 A
